ロード中...
Prognostic Clinical and Radiographic Biomarkers for BRAF‐Targeted Therapy in Advanced Melanoma
Agents blocking BRAF and MEK produce robust responses in patients with BRAF (V600)‐mutated melanoma; however, more accurate clinical biomarkers are needed to predict prognosis. To explore this question, we retrospectively studied 158 patients with BRAF‐mutated melanoma treated with BRAF with or with...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873326/ https://ncbi.nlm.nih.gov/pubmed/33044751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13562 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|